Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancer

Abstract Background To assess the utility of the TCGA molecular classification of endometrial cancer in a well-annotated, moderately sized, consecutive cohort of Chinese patients with ovarian clear cell carcinoma (OCCC). Methods We performed DNA sequencing on 80 OCCC patients via a panel that contai...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Chen, Lu Yan, Qin Li, Shuling Zhou, Ting Hou, Huijuan Yang, Shuang Ye
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-13389-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594658384936960
author Wei Chen
Lu Yan
Qin Li
Shuling Zhou
Ting Hou
Huijuan Yang
Shuang Ye
author_facet Wei Chen
Lu Yan
Qin Li
Shuling Zhou
Ting Hou
Huijuan Yang
Shuang Ye
author_sort Wei Chen
collection DOAJ
description Abstract Background To assess the utility of the TCGA molecular classification of endometrial cancer in a well-annotated, moderately sized, consecutive cohort of Chinese patients with ovarian clear cell carcinoma (OCCC). Methods We performed DNA sequencing on 80 OCCC patients via a panel that contains 520 cancer-related genes. The TCGA molecular subtyping method was utilized for classification. The clinicopathological features were analysed, and the survival correlation was assessed for each subtype. Results The most common mutated genes were ARID1A (49%) and PIK3CA (48%). No pathogenic POLE mutations were detected. MSI-high (MSI-H) tumours were observed in 5 (6.3%) patients. A total of 16.3% (13/80) of the patients were classified as the p53 abnormal (p53abn) subtype, and 77.5% (62/80) were classified as the nonspecific molecular profile (NSMP) subtype. All the MSI-H patients had ARID1A mutations, whereas patients with the p53abn subtype had the lowest percentage of ARID1A mutations (27.3%). No significant differences were observed between the molecular subtypes and clinicopathological features. The progression-free survival and overall survival of the entire cohort were closely associated with FIGO stage (p < 0.01), the presence of residual tumour (p < 0.01), and the platinum response (p < 0.01). Molecular classification did not significantly impact prognosis. Univariate analysis revealed that TP53 mutations in advanced-stage (FIGO III-IV) patients were associated with shorter survival. Conclusions We did not find prognostic significance of TCGA molecular subtyping in OCCC. POLEmuts are extremely rare, and the incidence of MSI-H and p53abn tumours is also quite low. Further subtyping of the NSMP subgroup is warranted.
format Article
id doaj-art-e5d6797d8dda4e3ca5a22dcebaa95fd0
institution Kabale University
issn 1471-2407
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-e5d6797d8dda4e3ca5a22dcebaa95fd02025-01-19T12:27:01ZengBMCBMC Cancer1471-24072025-01-0125111010.1186/s12885-024-13389-xMolecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancerWei Chen0Lu Yan1Qin Li2Shuling Zhou3Ting Hou4Huijuan Yang5Shuang Ye6Department of Gynecologic Oncology, Fudan University Shanghai Cancer CentreDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer CentreDepartment of Pathology, Fudan University Shanghai Cancer CentreDepartment of Pathology, Fudan University Shanghai Cancer CentreBurning Rock BiotechDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer CentreDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer CentreAbstract Background To assess the utility of the TCGA molecular classification of endometrial cancer in a well-annotated, moderately sized, consecutive cohort of Chinese patients with ovarian clear cell carcinoma (OCCC). Methods We performed DNA sequencing on 80 OCCC patients via a panel that contains 520 cancer-related genes. The TCGA molecular subtyping method was utilized for classification. The clinicopathological features were analysed, and the survival correlation was assessed for each subtype. Results The most common mutated genes were ARID1A (49%) and PIK3CA (48%). No pathogenic POLE mutations were detected. MSI-high (MSI-H) tumours were observed in 5 (6.3%) patients. A total of 16.3% (13/80) of the patients were classified as the p53 abnormal (p53abn) subtype, and 77.5% (62/80) were classified as the nonspecific molecular profile (NSMP) subtype. All the MSI-H patients had ARID1A mutations, whereas patients with the p53abn subtype had the lowest percentage of ARID1A mutations (27.3%). No significant differences were observed between the molecular subtypes and clinicopathological features. The progression-free survival and overall survival of the entire cohort were closely associated with FIGO stage (p < 0.01), the presence of residual tumour (p < 0.01), and the platinum response (p < 0.01). Molecular classification did not significantly impact prognosis. Univariate analysis revealed that TP53 mutations in advanced-stage (FIGO III-IV) patients were associated with shorter survival. Conclusions We did not find prognostic significance of TCGA molecular subtyping in OCCC. POLEmuts are extremely rare, and the incidence of MSI-H and p53abn tumours is also quite low. Further subtyping of the NSMP subgroup is warranted.https://doi.org/10.1186/s12885-024-13389-xOvarian clear cell carcinomaNext-generation sequencingTCGA subtypesPrognosisMolecular subclassificationMicrosatellite instability
spellingShingle Wei Chen
Lu Yan
Qin Li
Shuling Zhou
Ting Hou
Huijuan Yang
Shuang Ye
Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancer
BMC Cancer
Ovarian clear cell carcinoma
Next-generation sequencing
TCGA subtypes
Prognosis
Molecular subclassification
Microsatellite instability
title Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancer
title_full Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancer
title_fullStr Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancer
title_full_unstemmed Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancer
title_short Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancer
title_sort molecular subtype of ovarian clear cell carcinoma an analysis of 80 chinese patients using the tcga molecular classification of endometrial cancer
topic Ovarian clear cell carcinoma
Next-generation sequencing
TCGA subtypes
Prognosis
Molecular subclassification
Microsatellite instability
url https://doi.org/10.1186/s12885-024-13389-x
work_keys_str_mv AT weichen molecularsubtypeofovarianclearcellcarcinomaananalysisof80chinesepatientsusingthetcgamolecularclassificationofendometrialcancer
AT luyan molecularsubtypeofovarianclearcellcarcinomaananalysisof80chinesepatientsusingthetcgamolecularclassificationofendometrialcancer
AT qinli molecularsubtypeofovarianclearcellcarcinomaananalysisof80chinesepatientsusingthetcgamolecularclassificationofendometrialcancer
AT shulingzhou molecularsubtypeofovarianclearcellcarcinomaananalysisof80chinesepatientsusingthetcgamolecularclassificationofendometrialcancer
AT tinghou molecularsubtypeofovarianclearcellcarcinomaananalysisof80chinesepatientsusingthetcgamolecularclassificationofendometrialcancer
AT huijuanyang molecularsubtypeofovarianclearcellcarcinomaananalysisof80chinesepatientsusingthetcgamolecularclassificationofendometrialcancer
AT shuangye molecularsubtypeofovarianclearcellcarcinomaananalysisof80chinesepatientsusingthetcgamolecularclassificationofendometrialcancer